7150 rue Frederick-Banting, Suite 200
Saint-Laurent, H4S 2A1
Canada
Phone: (514) 282-9990
Fax: (514) 282-9990
Description:
BioAxone Therapeutic, a neuroscience company, is developing an experimental therapy for the treatment of neurological disorders. Our lead drug, Cethrin, is in clinical trial for spinal cord injury throughout Canada and the United States. The modified C3 exoenzyme provides neuroprotection and neuroregeneration by inhibiting Rho GTPase signaling.